Descriptor English: | Methysergide | ||||||
Descriptor Spanish: |
Metisergida
| ||||||
Descriptor Portuguese: | Metisergida | ||||||
Descriptor French: | Méthysergide | ||||||
Entry term(s): |
Deseril Desril Dimaleate, Methysergide Dimethylergometrin Désernil Sandoz Désernil-Sandoz Maleate, Methysergide Methylmethylergonovine Methysergide Dimaleate Methysergide Maleate Sansert UML 491 UML-491 UML491 |
||||||
Tree number(s): |
D03.132.327.287.689 D03.633.400.439.689 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D008784 | ||||||
Scope note: | An ergot derivative that is a congener of LYSERGIC ACID DIETHYLAMIDE. It antagonizes the effects of serotonin in blood vessels and gastrointestinal smooth muscle, but has few of the properties of other ergot alkaloids. Methysergide is used prophylactically in migraine and other vascular headaches and to antagonize serotonin in the carcinoid syndrome. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Serotonin Antagonists Vasoconstrictor Agents |
||||||
Registry Number: | XZA9HY6Z98 | ||||||
CAS Type 1 Name: | Ergoline-8-carboxamide, 9,10-didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethyl-, (8beta(S))- | ||||||
Public MeSH Note: | 65; METHYSERGIDE DERIVATIVES was see under METHYSERGIDE 1975-77; was see under ERGOLINES 1969-74 |
||||||
Online Note: | use METHYSERGIDE/analogs & derivatives to search METHYSERGIDE DERIVATIVES 1975-77; use ERGOLINES 1969-74 |
||||||
History Note: | 65(63); METHYSERGIDE DERIVATIVES was see under METHYSERGIDE 1975-77; was see under ERGOLINES 1969-74 |
||||||
DeCS ID: | 8973 | ||||||
Unique ID: | D008784 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1965/01/01 | ||||||
Date of Entry: | 1999/01/01 | ||||||
Revision Date: | 2017/05/24 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Methysergide
- Preferred
UML-491
- Narrower
Sansert
- Narrower
Methysergide Dimaleate
- Narrower
Methysergide Maleate
- Narrower
Concept UI |
M0013673 |
Scope note | An ergot derivative that is a congener of LYSERGIC ACID DIETHYLAMIDE. It antagonizes the effects of serotonin in blood vessels and gastrointestinal smooth muscle, but has few of the properties of other ergot alkaloids. Methysergide is used prophylactically in migraine and other vascular headaches and to antagonize serotonin in the carcinoid syndrome. |
Preferred term | Methysergide |
Entry term(s) |
Dimethylergometrin Methylmethylergonovine |
Concept UI |
M0352827 |
Preferred term | UML-491 |
Entry term(s) |
UML 491 UML491 |
Concept UI |
M0013675 |
Preferred term | Sansert |
Entry term(s) |
Deseril Desril Désernil Sandoz Désernil-Sandoz |
Concept UI |
M0013674 |
Preferred term | Methysergide Dimaleate |
Entry term(s) |
Dimaleate, Methysergide |
Concept UI |
M0352828 |
Preferred term | Methysergide Maleate |
Entry term(s) |
Maleate, Methysergide |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey